Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(12)
•••
Comment by coalbeton Sep 10, 2018 5:21pm
66 Views
Post# 28593356

RE:RE:RE:RE:RE:Re huge up 38 percent today

RE:RE:RE:RE:RE:Re huge up 38 percent today

It's not about Canada

Let's first address what isn't the primary reason to avoid buying Canadian marijuana stocks. It's not that the country is heading for a massive supply glut of cannabis.

Am I saying that supply won't outstrip demand in the near future? Not at all. I think that's exactly what will happen. It doesn't take a genius to compare the annual production capacity that the top growers are projecting against estimates for Canadian demand for cannabis to know that a glut is coming.

I don't think, though, that the inevitable supply glut in Canada is the top reason to stay away from Canadian marijuana stocks. Why? The executives of the biggest marijuana growers in the country know what's in store and aren't too concerned about it.

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities